Palantir Is Growing at a Jaw-Dropping Rate, but Is the Stock a Buy?

Palantir posted 85% year-over-year revenue growth, with its commercial segment up 104% and a 53% GAAP profit margin in Q1, highlighting unusually strong fundamentals. Despite the operating strength, the article argues the stock is expensive at about 93x forward earnings and 154x trailing earnings, with several years of growth already priced in. The overall view is constructive on the business but cautious on the stock due to valuation.

Analysis

The market’s mistake is not underestimating growth; it is conflating durable compounding with valuation durability. For a high-multiple software name, the key variable is not whether growth stays strong this quarter, but whether growth can outpace the compression in implied future returns as the law of large numbers and customer concentration start to matter more over the next 4-8 quarters. At this setup, even flawless execution can lead to flat-to-down stock performance if sequential beats are merely “good” instead of “exceptional.”

The more interesting second-order effect is competitive: if PLTR keeps winning in both public sector and regulated enterprise, it validates AI decisioning as a budget line item rather than a pilot project, which could pull spend from legacy data stacks, consultancies, and bespoke integration vendors. That is positive for platform software broadly, but it also raises the bar for peers that monetize AI through lower-margin services or model-layer tooling; the market may eventually reward the picks-and-shovels with better risk/reward than the application winner at 90x+ earnings.

The contrarian read is that the stock is not expensive because growth is slowing; it is expensive because the crowd already believes growth is structurally inevitable. That creates asymmetric downside on any modest guide-down, procurement delay, or re-rating in high-duration equities if rates back up. In the next 1-3 months, the path dependency matters more than the fundamentals: the name can still work, but the margin for error is effectively zero.

NVDA is only a partial comp because its multiple is supported by a much broader addressable market and clearer capex-backed demand visibility. PLTR lacks that same hardware-driven purchase commitment, so its valuation is more vulnerable to narrative fatigue. The most actionable opportunity is not chasing PLTR strength, but using it as a source of funding for higher-quality AI exposure with better cash-flow visibility.

Key Decisions for Investors

• Avoid initiating new long PLTR exposure at current levels; if already long, trim 25-50% into strength over the next 1-2 weeks and retain only a core position for a potential 6-12 month fundamental re-rate.
• Pair trade: long NVDA / short PLTR for 3-6 months. Thesis: NVDA has superior earnings visibility and a lower forward multiple; if AI spend rotates from narrative to delivered capex, NVDA should outperform on both multiple and fundamentals.
• For traders comfortable with options, buy PLTR put spreads 2-4 months out using earnings-week volatility. Risk/reward is favorable if the market needs only a small guide disappointment or macro wobble to de-rate the name 15-25%.
• Use PLTR strength to rotate into higher-conviction AI beneficiaries with cheaper duration, such as NVDA or infrastructure-linked semis, where growth is still underwritten by tangible capex cycles rather than sentiment alone.
• Set a tactical stop-loss on PLTR longs below the next major technical support; if the stock fails to hold after an earnings beat, treat it as a signal that the multiple, not the business, is now the binding constraint.